• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Virtual Second Opinions Saves $8,700 Per Patient, Study Reveals

by Fred Pennic 04/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
 Virtual Second Opinions Saves $8,700 Per Patient, Study Reveals

What You Should Know:

– A new study by The Clinic by Cleveland Clinic, a leader in virtual second opinions (VSOs), reveals significant cost savings and improved care for patients.

– The quantitative analysis, conducted by an independent third party, demonstrates that VSOs generate an average savings of $8,705 per patient.

Reduced Misdiagnoses and Overtreatment Lead to Cost Savings

The study highlights the potential for VSOs to prevent misdiagnoses and unnecessary procedures.  Key findings include:

  • Average Savings: VSOs deliver an average savings of $8,705 per patient. For complex cases with initial treatment plans exceeding $10,000, the average savings jump to a remarkable $100,911.
  • Reduced Overtreatment: The Clinic’s VSOs recommended alternative treatment plans in 67% of cases. This included a shift away from surgery in 85% of cases where surgery was initially recommended, and a 62% reduction in recommended hospitalizations compared to the original treatment plans.
  • Improved Diagnosis: Misdiagnosis is a significant healthcare concern, with estimates suggesting 800,000 deaths or disabilities annually in the US. VSOs from expert specialists can help prevent misdiagnoses and ensure patients receive the most appropriate treatment.

Impact Across Medical Specialties:

The study also revealed specific cost savings within various medical specialties:

  • Musculoskeletal (MSK): $28,220 average savings per patient
  • Cardiovascular: $8,036 average savings per patient
  • Cancer: $4,306 average savings per patient

Beyond Cost Savings: Improved Patient Wellbeing

While cost savings are significant, the study emphasizes the profound impact VSOs can have on patient well-being. Frank McGillin, CEO of The Clinic by Cleveland Clinic, underscores this point:

“Imagine discovering an alternative treatment that is less invasive and has better outcomes… The difference The Clinic can make in the cost of care matters, but the impact of getting care right is even more powerful.”

Rigorous Analysis Ensures Credibility:

The study’s credibility is bolstered by the methodology. Vital Statistics, LLC, an independent firm, conducted the analysis. Using a random sample of 300 patient charts from 2023, they employed medical coding and established cost data to calculate the associated savings.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |